COMMUNIQUÉS West-GlobeNewswire

Jade Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update
13/11/2025
Presented favorable preclinical safety data for JADE101 and a translational analysis of APRIL mediated biomarker responses at the American Society of Nephrology Kidney Week 2025, reinforcing its potential as a best-in- [...]
PacBio to Present at Upcoming Investor Conferences
13/11/2025
MENLO PARK, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the [...]
STRATA Skin Sciences Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
13/11/2025
HORSHAM, Penn., Nov. 13, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative [...]
Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights
13/11/2025
Company to submit Investigational Device Exemption (IDE) to FDA for novel CBGM technology in Spring 2026 Expanded clinical advisory team with appointment of pain management and medical technology expert, Usman Latif, MD [...]
BioStem Technologies Reports Third Quarter 2025 Financial Results
13/11/2025
POMPANO BEACH, Fla., Nov. 13, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for [...]
Daré Bioscience Reports Third Quarter 2025 Financial Results and Provides Corporate Update
13/11/2025
DARE to PLAY™ Sildenafil Cream on Track to Launch Before Year End via 503B Pathway, Paving the Way for Near-Term Product Revenue Positive Interim DSMB Outcome for Ovaprene® Phase 3 Study Supports Continued Enrollment [...]
Amneal Receives U.S. FDA Approval for Iohexol Injection
13/11/2025
First-to-market complex injectable with expected launch in Q1 2026 BRIDGEWATER, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced the U.S. [...]
Fennec Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
13/11/2025
~ Q3 2025 Total Net Product Sales of $12.5 Million, 79% Year Over Year Growth ~ ~ Q3 2025 Positive Cash Flow from Operations, Cash Position Grew to $22 Million ~ ~ Japan Clinical Trial (STS-J01) Preliminary Results [...]
Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress
13/11/2025
Conference call today, November 13, 2025, at 4:30 PM ET SAN DIEGO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the third quarter ended September 30, 2025 [...]
AEON Biopharma Reports Positive and Robust Biosimilarity Results: Identical Amino Acid Sequence and Highly Similar Functional Analysis Data
13/11/2025
- 100% match of visible amino acid sequence confirmed between ABP-450 and BOTOX® - - Functional assays demonstrate strong similarity in potency and composition, with directionally consistent enzymatic activity results [...]
Pure Harvest Corporate Group (OTC: PHCG) Completes its Acquisition of Mixie IP Holdings and Mixie Labs
13/11/2025
Adds AI-driven media technology, digital twin, immersive video, and immersive training IP; establishes paths to recurring software and services revenue across property operations, healthcare training and social gaming [...]
Candel Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
13/11/2025
Presented new subgroup analyses from phase 3 clinical trial of CAN-2409 in localized prostate cancer at the American Society for Radiation Oncology (ASTRO) 2025 meeting, demonstrating improved prostate cancer-specific [...]
Nanox to Launch FDA-Cleared Nanox.ARC X and Present development of new AI innovations at RSNA 2025 Annual Meeting
13/11/2025
Live demonstrations of Nanox.ARC X to be featured at RSNA booth ( 3914, South Hall Level 3) every 30 minutes Innovation Theater p resentation to highlight development of pulmonary nodule AI solution, as future component [...]
Biofrontera Inc. Reports Third Quarter 2025 Financial Results and Provides a Business Update
13/11/2025
Conference call will be held today, Thursday, November 13 at 10:00 am ET Woburn, MA, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the [...]
La MHRA approuve la demande d’essai clinique de BetaGlue Therapeutics pour YntraDose™ dans le traitement du cancer du pancréas localement avancé non résécable (uLA-PDAC)
13/11/2025
MILAN, 13 nov. 2025 (GLOBE NEWSWIRE) -- BetaGlue ® Therapeutics (« BetaGlue » ou la « Société »), une société d’oncologie en phase clinique développant une solution innovante de radiothérapie pour le traitement ciblé [...]
SCIENTURE Reports Q3 2025 Financial Results and Provides Business Update
13/11/2025
Reports Significant Revenue Growth to $590K and Substantial Increase in Gross Profit to $575K Launched Sales of Arbli ™ , the First FDA-Approved Ready-To-Use Liquid Formulation of Losartan for Hypertension COMMACK, NY, [...]
Matisse Pharmaceuticals successfully completes study with prolonged infusion of M6229 in healthy volunteers
13/11/2025
Geleen, November 13 th , 2025. Matisse Pharmaceuticals B.V., a clinical stage company developing a medicinal product for the treatment of sepsis, today announced top line results from its phase 1 study evaluating the [...]
GenoSafe strengthens its leadership in analytical expertise with the opening of new GMP-compliant laboratories to support the advanced therapies sector
13/11/2025
GenoSafe strengthens its leadership in analytical expertise with the opening of new GMP-compliant laboratories to support the advanced therapies sector Évry-Courcouronnes , France, N ovemb er 16th , 2025 - GenoSafe, the [...]
GenoSafe étend son leadership en expertise analytique avec l’ouverture de nouveaux laboratoires aux standards internationaux pour soutenir la filière des thérapies innovantes
13/11/2025
GenoSafe étend son leadership en expertise analytique avec l’ouverture de nouveaux laboratoires aux standards internationaux pour soutenir la filière des thérapies innovantes Évry-Courcouronnes , le 13 novembre 2025 - [...]

Pages